HINDALCO Board to Meet on May 22, 2026, to Approve FY26 Results and Final Dividend

Hindalco Industries Limited has announced a crucial Board Meeting scheduled for Friday, May 22, 2026. The primary agenda items include the consideration and approval of the Audited Standalone and Consolidated financial results for the quarter and full year ending March 31, 2026. Additionally, the Board will recommend any final dividend for the financial year 2025-2026. Concurrently, the company confirmed that the Trading Window for securities will be closed from April 1, 2026, until May 25, 2026.

Key Dates for Financial Results and Trading Window

Hindalco Industries Limited has formally informed the stock exchanges regarding important corporate actions stemming from its upcoming Board review. A meeting of the Board of Directors is scheduled to convene on Friday, May 22, 2026.

The central purpose of this meeting is dual-fold:

  1. To consider and approve the Audited Standalone and Consolidated financial results for the entire financial year and the quarter concluding on March 31, 2026 (referred to as the “said results”).
  2. To consider and recommend a final dividend, if deemed appropriate, on the company’s equity shares for the financial year ended March 31, 2026.

Trading Window Closure Details

In anticipation of the announcement of the said results, the company has mandated a closure of the ‘Trading Window’ for all dealings in the securities of Hindalco. This restriction will take effect starting from Wednesday, April 1, 2026. The window is scheduled to reopen on Monday, May 25, 2026. This communication has been disseminated to all Designated Persons as required by the internal Code of Conduct.

Earnings Conference Call Update

Following the formal declaration of the financial performance, Hindalco plans to host an Earnings Conference Call to discuss the results in detail with analysts and investors. Specific details concerning the date and time of this call will be announced separately in due course.

The complete filing, including the regulatory references (Scrip Codes: 500440/HINDALCO; ISIN: INE038A01020), is available on the company’s official website, www.hindalco.com.

Source: BSE

Previous Article

Ajanta Pharma Limited Promoter Ravi Agrawal Discloses Pledge Creation and Release for Refinancing

Next Article

Vedant Fashions (Manyavar) Rescheduling of Analyst Investor Meetings Originally Set for March 23, 2026